Muhammad Shafiq

Prof. Muhammad Shafiq

Shantou University Medical College, Shantou, Guangdong, China
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Computational and Structural Biotechnology Journal
Verified
Journal Article
Open access
Hazrat BilalHazrat Bilal
Hazrat Bilal
MKMuhammad Nadeem Khan
Muhammad Nadeem Khan
SKSabir Khan
Sabir Khan
Muhammad ShafiqMuhammad Shafiq
Muhammad Shafiq
WFWenjie Fang
Wenjie Fang
BXBin Xu
Bin Xu
Antimicrobial resistance (AMR) is a major threat to global public health. The current review synthesizes to address the possible role of Artificial Intelligence and Machine Learning (AI/ML) in mitigating AMR. Supervised learning, unsupervised learning, deep learning, reinforcement learning, and natural language processing are some of the main tools used in this domain. AI/ML models can use various data sources, such as clinical information, genomic sequences, microbiome insights, and epidemiological data for predicting AMR outbreaks. Although AI/ML are relatively new fields, numerous case studies offer substantial evidence of their successful application in predicting AMR outbreaks with greater accuracy. These models can provide insights into the discovery of novel antimicrobials, the repurposing of existing drugs, and combination therapy through the analysis of their molecular structures. In addition, AI-based clinical decision support systems in real-time guide healthcare professionals to improve prescribing of antibiotics. The review also outlines how can AI improve AMR surveillance, analyze resistance trends, and enable early outbreak identification. Challenges, such as ethical considerations, data privacy, and model biases exist, however, the continuous development of novel methodologies enables AI/ML to play a significant role in combating AMR.

18 September 2022 in Virulence
Verified
Journal Article
Open access
Hazrat BilalHazrat Bilal
Hazrat Bilal
Muhammad ShafiqMuhammad Shafiq
Muhammad Shafiq
BHBing Hou
Bing Hou
Rehmat IslamRehmat Islam
Rehmat Islam
MKMuhammad Nadeem Khan
Muhammad Nadeem Khan
Yuebin ZengYuebin Zeng
Yuebin Zeng
Antifungal resistance to Candida pathogens increases morbidity and mortality of immunosuppressive patients, an emerging crisis worldwide. Understanding the Candida prevalence and antifungal susceptibility pattern is necessary to control and treat candidiasis. We aimed to systematically analyse the susceptibility profiles of Candida species published in the last ten years (December 2011 to December 2021) from mainland China. The studies were collected from PubMed, Google Scholar, and Science Direct search engines. Out of 89 included studies, a total of 44,716 Candida isolates were collected, mainly comprising C. albicans (49.36%), C. tropicalis (21.89%), C. parapsilosis (13.92%), and C. glabrata (11.37%). The lowest susceptibility was detected for azole group; fluconazole susceptibilities against C. parapsilosis, C. albicans, C. glabrata, C. tropicalis, C. guilliermondii, C. pelliculosa, and C. auris were 93.25%, 91.6%, 79.4%, 77.95%, 76%, 50%, and 0% respectively. Amphotericin B and anidulafungin were the most susceptible drugs for all Candida species. Resistance to azole was mainly linked with mutations in ERG11, ERG3, ERG4, MRR1–2, MSH-2, and PDR-1 genes. Mutation in FKS-1 and FKS-2 in C. auris and C. glabrata causing resistance to echinocandins was stated in two studies. Gaps in the studies’ characteristics were detected, such as 79.77%, 47.19 %, 26.97%, 7.86%, and 4.49% studies did not mention the mortality rates, age, gender, breakpoint reference guidelines, and fungal identification method, respectively. The current study demonstrates the overall antifungal susceptibility pattern of Candida species, gaps in surveillance studies and risk-reduction strategies that could be supportive in candidiasis therapy and for the researchers in their future studies.

10 November 2022 in Frontiers in Microbiology
Verified
Journal Article
Open access
Muhammad ShafiqMuhammad Shafiq
Muhammad Shafiq
MZMi Zeng
Mi Zeng
BPBudi Permana
Budi Permana
Hazrat BilalHazrat Bilal
Hazrat Bilal
JHJinhu Huang
Jinhu Huang
XJXiaoyang Jiao
Xiaoyang Jiao
The emergence of pathogens is conferring resistance to last-resort therapies such as tigecycline, colistin, and carbapenems, limiting the therapeutic options, and raising concerns about the emergence of new “superbugs.” This study reports the first incident of a blaNDM–5 and tet(X4) co-harboring Escherichia coli with resistance to carbapenem and tigecycline recovered as the causative agent of a urinary tract infection in a 94-year-old patient. The E. coli strain ECCL209 carries multiple resistance genes [i.e., blaTEM–1B, blaNDM–5, blaCMY–2, aadA22, florR, erm(B), mph(A), erm(42), lnuG, qnrS1, and sul2] and exhibits resistance to almost all clinically used antibiotics. MLST analysis found that the strain belongs to ST648, considered a worldwide high-risk pandemic clone. Moreover, multiple plasmid incompatibility types were detected, i.e., IncHI1A, IncHI1B, IncFII, IncFIA, IncFIB, IncQ1, Col, and IncX4. Genetic analysis revealed that blaNDM–5 and tet(X4) genes were localized on two hybrid plasmids with multiple replicons. Continuous monitoring studies are suggested to quantify the antimicrobial resistance and assess the dissemination of such superbugs into a human healthcare setting.

4 June 2022 in Molecular Immunology
Verified
Journal Article
Closed access
IAIlyas Ali
Ilyas Ali
CLChengmin Li
Chengmin Li
MKMeqian Kuang
Meqian Kuang
ASAbid Ullah Shah
Abid Ullah Shah
Muhammad ShafiqMuhammad Shafiq
Muhammad Shafiq
GWGenlin Wang
Genlin Wang

1 January 2021 in Microbial Pathogenesis
Verified
Journal Article
Closed access
Muhammad ShafiqMuhammad Shafiq
Muhammad Shafiq
JHJinhu Huang
Jinhu Huang
JSJan Mohammad Shah
Jan Mohammad Shah
IAIlyas Ali
Ilyas Ali
SRSadeeq Ur Rahman
Sadeeq Ur Rahman
LWLiping Wang
Liping Wang

1 July 2019 in Infection and Drug Resistance
Verified
Journal Article
Open access
PDF file
Muhammad ShafiqMuhammad Shafiq
Muhammad Shafiq
JHJinhu Huang
Jinhu Huang
SRSadeeq Ur Rahman
Sadeeq Ur Rahman
JSJan Mohammad Shah
Jan Mohammad Shah
LCLi Chen
Li Chen
LWLiping Wang
Liping Wang
Purpose: The coexistence of mobile colistin (COL)-resistant gene mcr-1 with extended-spectrum beta-lactamase (ESBL) gene in Escherichia coli has become a serious threat globally. The aim of this study was to investigate the increasing resistance to COL and in particular its coexistence with ESBL-producing E. coli recovered from pig farms in China. Materials and methods: E. coli were isolated from 14 pig farms in Jiangsu China. Susceptibility testing was identified by micro-dilution method. PCR assay and nucleotide sequencing were used to detect COL-resistant genes, mcr-1 to −5, as well as ESBL genes, blaCTX-M, blaSHV and blaTEM. Conjugation experiment, plasmid replicon typing of the multidrug resistance (MDR), S1-PFGE and DNA southern hybridization were performed to study the transferability of these genes. Results: Overall, 275 E. coli isolates were recovered from a total of 432 cloacal and nasal swabs. More than 90% of the isolates were MDR, of which 70.18% were resistant to COL. Of these 275 isolates, mcr-1 was identified as the most predominant gene carried by 71.63% (197/275) of isolates, 39.59% (78/197) of the isolates were harboring both mcr-1 and ESBL genes (blaCTX-M, blaSHV and blaTEM). ESBL genotyping showed that blaCTX-M was the most predominant ESBL (68.49%) followed by blaSHV (16.4%) and blaTEM (15%). Sequencing revealed that the most common variants of blaCTX-M identified were, blaCTX-M-15 (69%), blaCTX-M-55 (29%) and blaCTX-M-1 (1.8%). IncHI2, IncFIB, IncFIC, IncN and IncX4 were found to be the most common Inc-types found both in donors and in transconjugants and were associated with the transfer of the mcr-1 and ESBL encoding genes. Six strains carried a total of five different plasmids: approximately 97-, 130-, 160-, 227- and 242-kb plasmids. Conclusion: The coexistence of the mcr-1- and blaCTX-M-15-carrying isolates displaying high MDR, recovered from E. coli of pig origin, is a major concern for both humans and veterinary medicine.